Frontiers of Fighting Scleroderma
Dr. Richard Sontheimer discusses a new class of small molecule oral drugs to treat later stage disease of systemic sclerosis. Richard D. Sontheimer, MD, is a clinical professor of dermatology at the University of Utah School of Medicine. “This patient creates a lot of angst when they show up in our clinics because it’s one […]